Loading...
XSHE002432
Market cap2.74bUSD
Jan 17, Last price  
39.81CNY
Name

Andon Health Co Ltd

Chart & Performance

D1W1MN
XSHE:002432 chart
P/E
16.09
P/S
6.23
EPS
2.47
Div Yield, %
5.85%
Shrs. gr., 5y
1.35%
Rev. gr., 5y
41.79%
Revenues
3.23b
-87.72%
216,942,081279,505,070313,158,124298,701,604354,131,710356,081,981407,567,065425,451,964397,858,037420,138,125597,918,934563,880,299706,276,4062,008,360,2202,397,097,77726,315,360,9173,231,124,896
Net income
1.25b
-92.19%
43,905,43731,304,47339,040,60823,716,12820,806,6966,982,945010,197,500014,497,917012,686,75527,059,605242,329,254908,642,43316,030,169,0771,251,608,151
CFO
2.02b
-88.93%
37,140,7802,535,39942,707,961005,234,76400000-104,174,5670461,622,751293,114,03118,221,682,9592,017,576,784
Dividend
Jun 04, 20240.3 CNY/sh
Earnings
May 21, 2025

Profile

Andon Health Co., Ltd. develops, manufactures, and sells health electronics and intelligent hardware products. It offers sphygmomanometers, nebulizers, blood glucose meters, thermometers, fetal heart rate instruments, electrocardiographs, oximeters, smart watches, and body weight scales. The company was founded in 1995 and is based in Tianjin, China.
URL
https://www.jiuan.com/
IPO date
Jun 10, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,231,125
-87.72%
26,315,361
997.80%
Cost of revenue
2,164,683
7,208,241
Unusual Expense (Income)
NOPBT
1,066,442
19,107,120
NOPBT Margin
33.01%
72.61%
Operating Taxes
231,112
1,773,763
Tax Rate
21.67%
9.28%
NOPAT
835,330
17,333,357
Net income
1,251,608
-92.19%
16,030,169
1,664.19%
Dividends
(1,177,480)
(319,170)
Dividend yield
6.91%
1.34%
Proceeds from repurchase of equity
(1,975,558)
139,144
BB yield
11.60%
-0.58%
Debt
Debt current
1,200,000
287,936
Long-term debt
332,184
59,630
Deferred revenue
13,096
18,217
Other long-term liabilities
13,341
1
Net debt
(19,855,883)
(11,440,054)
Cash flow
Cash from operating activities
2,017,577
18,221,683
CAPEX
(212,653)
Cash from investing activities
(4,433,355)
Cash from financing activities
(922,782)
FCF
1,673,000
16,872,237
Balance
Cash
11,383,886
11,487,984
Long term investments
10,004,181
299,636
Excess cash
21,226,511
10,471,853
Stockholders' equity
19,029,130
18,488,117
Invested Capital
2,322,214
9,847,548
ROIC
13.73%
295.50%
ROCE
4.78%
90.22%
EV
Common stock shares outstanding
452,285
467,368
Price
37.67
-26.30%
51.11
3.15%
Market cap
17,037,574
-28.67%
23,887,190
6.06%
EV
(2,223,270)
12,917,619
EBITDA
1,174,063
19,213,169
EV/EBITDA
0.67
Interest
15,230
4,754
Interest/NOPBT
1.43%
0.02%